VAERS reports by lot

GSK Varicella/Shingles lot ER5ZB: VAERS reports

61 VAERS reports list lot ER5ZB as a GSK Varicella/Shingles vaccine, received between 2019-02-25 and 2021-03-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
8%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6521%
Injection-site / Local reaction4916%
Cardiac / Cardiovascular4314%
Dermatological (non-injection-site)3712%
Musculoskeletal3311%
Neurological279%
Gastrointestinal206%
Allergic / Anaphylactic186%
Respiratory93%
Thrombotic / Hematological52%
Psychiatric / Neuropsychiatric31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania10
Arizona6
California6
Hawaii4
Tennessee4
Washington3
Georgia3
Arkansas3
Alaska2
Indiana2
Colorado2
Nebraska1

Reports by month received

2019-022
2019-0326
2019-0415
2019-055
2019-064
2019-074
2019-081
2019-091
2019-101
2020-121
2021-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.